To the full analysis
Buyback calculator for Guardant Health
Guardant Health stock: key metrics
GHGuardant Health had an operating margin of −44.5% and a return on invested capital (ROIC) of −90.2% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2016 | 12.4% | −173.7% | −182.7% |
| 2017 | 36.6% | −153.7% | −167.0% |
| 2018 | 52.3% | −102.5% | −93.8% |
| 2019 | 67.0% | −38.4% | −35.3% |
| 2020 | 67.7% | −88.9% | −88.5% |
| 2021 | 67.1% | −110.0% | −108.6% |
| 2022 | 65.2% | −121.1% | −145.6% |
| 2023 | 59.7% | −100.1% | −85.0% |
| 2024 | 60.8% | −60.0% | −59.0% |
| 2025 | 64.5% | −44.5% | −42.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2016 | −57.9% | −33.9% | −39.6% |
| 2017 | −27.0% | −28.4% | −24.3% |
| 2018 | −17.6% | −75.7% | −14.5% |
| 2019 | −9.5% | −27.6% | −7.9% |
| 2020 | −19.5% | −51.6% | −11.2% |
| 2021 | −62.9% | −43.3% | −18.4% |
| 2022 | −100.0% | −57.2% | −40.7% |
| 2023 | −100.0% | −29.8% | −26.8% |
| 2024 | 200.0% | −24.7% | −29.4% |
| 2025 | 200.0% | −90.2% | −20.7% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 28 Feb 2021)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.